July 1, 2026
Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial
B Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced solid tumor patients SYDNEY,…
